<DOC>
	<DOCNO>NCT02294552</DOCNO>
	<brief_summary>This study evaluate efficacy high-dose post-transplantation cyclophosphomide graft-versus-host disease ( GVHD ) prophylaxis allogeneic stem cell transplantation patient different risk GVHD . The risk-adapted strategy involve use single-agent cyclophosphomide recipient match bone marrow graft , combine cyclophosphomide tacrolimus mycophenolate mofetil recipient match peripheral blood stem cell mismatch bone marrow .</brief_summary>
	<brief_title>Post-transplantation Cyclophosphamide GVHD Prophylaxis After HSCT</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Immune System Diseases</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Antineoplastic Agents , Alkylating</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Patients must indication allogeneic hematopoietic stem cell transplantation Signed informed consent Patients donor available . The donor recipient must identical least one allele follow genetic locus : HLAA , HLAB , HLACw , HLADRB1 , HLADQB1 . A minimum match 5/10 require related donor . A minimum match 8/10 require unrelated donor . No second tumor No severe concurrent illness Moderate severe cardiac dysfunction , leave ventricular ejection fraction &lt; 50 % Moderate severe decrease pulmonary function , FEV1 &lt; 70 % DLCO &lt; 70 % predict Respiratory distress &gt; grade I Severe organ dysfunction : AST ALT &gt; 5 upper normal limit , bilirubin &gt; 1.5 upper normal limit , creatinine &gt; 2 upper normal limit Creatinine clearance &lt; 60 mL/min Uncontrolled bacterial fungal infection time enrollment Requirement vasopressor support time enrollment Karnofsky index &lt; 30 % Pregnancy Somatic psychiatric disorder make patient unable sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Leukemia</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Myelodysplastic Syndromes</keyword>
	<keyword>Chronic Lymphocytic Leukemia</keyword>
	<keyword>Immunosuppressive Agents</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Busulfan</keyword>
	<keyword>Fludarabine</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Mycophenolate mofetil</keyword>
	<keyword>Antineoplastic Agents , Alkylating</keyword>
	<keyword>Myeloablative Agonists</keyword>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>Allogeneic</keyword>
</DOC>